Nanopeutics

Nanopeutics is a biotechnology company specializing in the development of bio-active nanofiber scaffolds designed for advanced wound care and tissue regeneration. The company's proprietary platform utilizes electrospinning technology to create biomimetic structures that closely resemble the human extracellular matrix, promoting cell migration and attachment. These nanofibers can be engineered to deliver therapeutic agents, such as antimicrobials or protease inhibitors, directly to the site of chronic and acute wounds. By addressing the complex microenvironment of non-healing wounds, Nanopeutics aims to provide superior clinical outcomes for patients suffering from diabetic foot ulcers and severe burns. The company's research is supported by significant expertise in matrix metalloproteinase (MMP) regulation and wound biochemistry.